Jim Simons Bristol Myers Squibb CO Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,060,533 shares of BMY stock, worth $63.7 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,060,533
Previous 908,538
16.73%
Holding current value
$63.7 Million
Previous $47 Million
27.58%
% of portfolio
0.09%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,764Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.53 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.77 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.72 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...